Sanofi Ventures

About The Fund

Sanofi Ventures is a corporate venture capital (CVC) fund headquartered in France, specializing in equity investments as a fund of funds. They focus on catalyzing early-stage biotech and digital health advancements by strategically investing in transformative science and technology. The fund's raison d'être is to provide an entry point to the innovation ecosystem for Sanofi, particularly targeting investments in companies at stages too early for partnership or acquisition. With a strong commitment to improving human health, they back top-tier biotech and digital health companies with the potential to enhance patient outcomes and revolutionize medical practice. Sanofi Ventures shows flexibility across all stages of the private company lifecycle, with an investment sweet spot of $7,500,000 and a range from $5,000,000 to $10,000,000. Their expertise allows them to lead financings, serve on boards, and work closely with portfolio companies to foster long-term value. Their specialties encompass Seed, Startup, Early Stage, Expansion, Later Stage, Series A, and Series B investments. With assets under management of $100,000,000, Sanofi Ventures demonstrates a notable presence in sectors including BioTech, IoT (& Wearables), A.I. (& Big Data), HealthTech (& Fitness), Medical Devices (& Hospital Services), Healthcare (& Wellness), Life Science, Nanotechnology, Consumer, Pharmaceutical (& Medicine), and Woman Focused industries. From Seed to Series B, they provide not just capital but also strategic support to entrepreneurs passionate about ushering in the miracles of science and humanitarian health advancements.